| Literature DB >> 34550913 |
Eriko Hayashi, Maho Aoyama, Fumiyasu Fukano, Junko Takano, Yoichi Shimizu, Mitsunori Miyashita.
Abstract
This observational, controlled study explored the effects of bathing on the physical and psychological aspects of terminal cancer patients on a palliative care ward. With nurses' assistance, the patients evaluated and recorded the severity of their symptoms at 10:00 am, 30 minutes after initial bathing, and at 5:00 pm. The bathing care was provided as routine care according to the patients' wishes. Twelve symptoms were measured using 9 items (numbers 1-9) from the Edmonton Symptom Assessment System-Revised Japanese version and 3 items from the Cancer Fatigue Scale. Outcomes were compared between bathing days and nonbathing days (control) and between before and after bathing. Of the 57 bathers, data were available for both bathing days and nonbathing days for 42 bathers. In the comparison between bathing and nonbathing days, tiredness was significantly improved (effect size [ES], 0.35; P = .02). On the basis of the pre-post bathing comparison, 6 symptoms, namely, tiredness (ES, 0.40; P < .01), lack of appetite (ES, 0.36; P = .01), decreased well-being (ES, 0.33; P = .01), anxiety (ES, 0.36; P = .01), pain (ES, 0.31; P = .02), and depression (ES, 0.30; P = .02), were significantly improved. Bathing in a tub effectively improves tiredness and might be effective for distressing symptoms in end-of-life cancer patients.Entities:
Mesh:
Year: 2022 PMID: 34550913 PMCID: PMC8728761 DOI: 10.1097/NJH.0000000000000803
Source DB: PubMed Journal: J Hosp Palliat Nurs ISSN: 1522-2179 Impact factor: 1.918
FIGURE 1.Enrollment of study subjects. RASS, Richmond Agitation-Sedation Scale.
Patients' Attributes
| Total | Bathers | Nonbathers |
| |||||
|---|---|---|---|---|---|---|---|---|
| N | % | n | % | n | % | |||
| Subject characteristic | ||||||||
| Sex | ||||||||
| Male | 38 | 51% | 30 | 53% | 8 | 44% | .55a | |
| Female | 37 | 49% | 27 | 47% | 10 | 56% | ||
| Age, y | ||||||||
| Median (interquartile range) | 77.0 (70.0–82.0) | 77.0 (70.0–83.0) | 76.5 (70.3–82.0) | .56b | ||||
| Cancer symptom and ADL | ||||||||
| Hospitalization period (palliative care ward), d | ||||||||
| Median no. days (interquartile range) | 15.0 (8.0–34.0) | 18.0 (8.5–35.0) | 9.5 (6.0–16.8) | .05b,c | ||||
| PS | ||||||||
| 1 | 0 | 0% | 0 | 0% | 0 | 0% | .54a | |
| 2 | 12 | 16% | 10 | 18% | 2 | 11% | ||
| 3 | 27 | 36% | 20 | 35% | 7 | 39% | ||
| 4 | 36 | 48% | 27 | 47% | 9 | 50% | ||
| Cancer site | ||||||||
| Lungs | 12 | 16% | 10 | 18% | 2 | 11% | .14a | |
| Liver, pancreas, gallbladder, bile duct | 20 | 27% | 14 | 25% | 6 | 33% | ||
| Esophagus, stomach | 21 | 28% | 16 | 28% | 5 | 28% | ||
| Colon, rectum | 7 | 9% | 5 | 9% | 2 | 11% | ||
| Kidney, bladder, prostate | 8 | 11% | 8 | 14% | 0 | 0% | ||
| Breast | 3 | 4% | 2 | 4% | 1 | 6% | ||
| Uterus, ovary | 1 | 1% | 0 | 0% | 1 | 6% | ||
| Other | 3 | 4% | 2 | 4% | 1 | 6% | ||
| Route of opioid administration | ||||||||
| Injected | 16 | 21% | 12 | 21% | 4 | 22% | .68a | |
| Oral/patch | 35 | 47% | 26 | 46% | 9 | 50% | ||
| None | 24 | 32% | 19 | 33% | 5 | 28% | ||
| Food intake | ||||||||
| Full amount | 18 | 24% | 15 | 26% | 3 | 17% | .08a | |
| Half | 17 | 23% | 16 | 28% | 1 | 6% | ||
| Small amount | 26 | 35% | 16 | 28% | 10 | 56% | ||
| None | 14 | 19% | 10 | 18% | 4 | 22% | ||
| Recuperative environment and bathing before transfer | ||||||||
| Place of care before administration/transfer to palliative care ward | ||||||||
| Home | 18 | 24% | 13 | 23% | 5 | 28% | .60a | |
| General ward | 56 | 75% | 43 | 76% | 13 | 72% | ||
| Institution | 1 | 1% | 1 | 2% | 0 | 0% | ||
| Final bath before transfer | ||||||||
| 6 mo before | 3 | 4% | 3 | 5% | 0 | 0% | .49a | |
| 1‐5 mo before | 22 | 29% | 17 | 30% | 5 | 28% | ||
| 1‐4 wk before | 40 | 53% | 30 | 53% | 10 | 56% | ||
| 2‐7 d before | 7 | 9% | 4 | 1% | 3 | 17% | ||
| The day before to the day of transfer | 3 | 4% | 3 | 5% | 0 | 0% | ||
| Frequency of bathing in a tub when healthy | ||||||||
| Daily | 69 | 92% | 53 | 93% | 16 | 89% | .45a | |
| 2‐3 times/wk | 4 | 5% | 3 | 5% | 1 | 6% | ||
| 1 time/wk | 1 | 1% | 0 | 0% | 1 | 6% | ||
| Showering only | 1 | 1% | 1 | 2% | 0 | 0% | ||
| Enjoyment of bathing in a tub when healthy | ||||||||
| Loved it | 70 | 93% | 53 | 93% | 17 | 94% | .57a | |
| Liked it | 2 | 3% | 2 | 4% | 0 | 0% | ||
| Did not like it much | 3 | 4% | 2 | 4% | 1 | 6% | ||
| Bathing after transfer | ||||||||
| Day of first bath after transfer | ||||||||
| Day of transfer | 2 | 4% | ||||||
| Second day | 23 | 40% | ||||||
| Third day | 8 | 14% | ||||||
| Fourth day | 9 | 16% | ||||||
| Fifth day | 8 | 14% | ||||||
| Sixth day | 2 | 4% | ||||||
| Seventh day | 5 | 9% | ||||||
Abbreviation: ADL, Activities of Daily Living.
Performance Status (PS) was quantified by nurses on the palliative care ward.
No correlation with bathing: aχ2 test and bWilcoxon rank sum test.
cP = .054, not significant (P > .05).
FIGURE 2.Comparison of differences in the scores for each item of the Edmonton Symptom Assessment System-Revised Japanese version and Cancer Fatigue Scale between bathing and nonbathing days. Effect size (ES): criteria recommended by Cramer for both φ and V: small effect, 0.1 to less than 0.3; moderate effect, 0.3 to less than 0.5; and large effect, 0.5 or greater. Score difference: difference between the evening and morning scores; subjects included 57 bathers who took a bath in a tub, of whom 42 had data available for both bathing and nonbathing days (Wilcoxon test, 5% significance level).
Changes in Symptom Scores After Bathing
| Symptom | Before Bathing | After Bathing | ES |
| Improved | No change | Worsened | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | n | % | n | % | n | % | |||
| Tiredness | 3.3 | 3.2 | 2.3 | 2.8 | 0.40 | <.01 | 24 | 42 | 24 | 42 | 9 | 16 |
| Anxiety | 1.3 | 2.2 | 0.7 | 1.7 | 0.36 | .01 | 13 | 23 | 42 | 74 | 2 | 4 |
| Lack of appetite | 2.6 | 3.5 | 1.7 | 2.9 | 0.36 | .01 | 12 | 21 | 43 | 75 | 2 | 4 |
| Decreased well-being | 2.3 | 2.9 | 1.6 | 2.3 | 0.33 | .01 | 18 | 32 | 35 | 61 | 4 | 7 |
| Pain | 1.4 | 2.4 | 1.0 | 1.7 | 0.31 | .02 | 16 | 28 | 37 | 65 | 4 | 7 |
| Depression | 1.3 | 2.3 | 0.8 | 1.9 | 0.30 | .02 | 14 | 25 | 40 | 70 | 3 | 5 |
| Shortness of breath | 0.9 | 2.1 | 0.7 | 1.7 | 0.24 | .07 | 9 | 16 | 46 | 81 | 2 | 4 |
| Nausea | 0.4 | 1.5 | 0.5 | 1.7 | 0.07 | .59 | 4 | 7 | 48 | 84 | 5 | 9 |
| Drowsiness | 3.1 | 3.1 | 3.2 | 3.3 | 0.08 | .57 | 15 | 26 | 26 | 46 | 16 | 28 |
| ESAS-r-J overall score | 16.6 | 16.5 | 12.4 | 13.6 | 0.47 | <.01 | 34 | 60 | 12 | 21 | 11 | 19 |
| Memory | 2.7 | 3.2 | 2.0 | 2.6 | 0.47 | <.01 | 18 | 32 | 37 | 65 | 2 | 4 |
| Attention | 2.9 | 2.9 | 2.3 | 2.4 | 0.42 | <.01 | 19 | 33 | 34 | 60 | 4 | 7 |
| Energy | 2.9 | 3.0 | 2.3 | 2.5 | 0.35 | .01 | 18 | 32 | 36 | 63 | 3 | 5 |
Abbreviation: ESAS-r-J, Edmonton Symptom Assessment System-Revised Japanese version.
Data were analyzed using Wilcoxon signed-rank test, 5% significance level.
Effect size (ES): criteria recommended by Cramer for both φ and V: small effect, 0.1 to less than 0.3; moderate effect, 0.3 to less than 0.5; and large effect, 0.5 or greater.
FIGURE 3.Comparison of mean scores for each item of the Edmonton Symptom Assessment System-Revised Japanese version (ESAS-r-J) and Cancer Fatigue Scale (CFS) before and after bathing in a tub. Effect size (ES): criteria recommended by Cramer for both φ and V: small effect, 0.1 to less than 0.3; moderate effect, 0.3 to less than 0.5; and large effect, 0.5 or greater (Wilcoxon test, 5% significance level).